Terms: = Thyroid cancer AND PSA AND Diagnosis
25 results:
1. Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying psa Nadir ≤ 0.05 ng/ml as marker for treatment response.
Kafka M; Burtscher T; Fritz J; Schmitz M; Bektic J; Ladurner M; Horninger W; Heidegger I
World J Urol; 2023 Aug; 41(8):2043-2050. PubMed ID: 36287244
[TBL] [Abstract] [Full Text] [Related]
2. Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
[TBL] [Abstract] [Full Text] [Related]
3. Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.
Klotz L
World J Urol; 2022 Jan; 40(1):1-8. PubMed ID: 33492425
[TBL] [Abstract] [Full Text] [Related]
4. Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report.
Williams SG; Aw Yeang HX; Mitchell C; Caramia F; Byrne DJ; Fox SB; Haupt S; Schittenhelm RB; Neeson PJ; Haupt Y; Keam SP
BMC Urol; 2020 Oct; 20(1):171. PubMed ID: 33115461
[TBL] [Abstract] [Full Text] [Related]
5. cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction.
Cioffi G; Viapiana O; Tarantini L; Ognibeni F; Orsolini G; Fassio A; Gatti D; Rossini M; Giollo A
Intern Emerg Med; 2021 Jan; 16(1):73-81. PubMed ID: 32221774
[TBL] [Abstract] [Full Text] [Related]
6. Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin.
Soliman ML; Tiwari A; Zhao Q
World J Gastroenterol; 2017 Feb; 23(6):1106-1112. PubMed ID: 28246485
[TBL] [Abstract] [Full Text] [Related]
7. [Prostate Carcinoma Mimics Lung Carcinoma: A Case Report].
Drosos K; Höfner K
Aktuelle Urol; 2017 Apr; 48(2):153-155. PubMed ID: 28081573
[TBL] [Abstract] [Full Text] [Related]
8. thyroid metastasis of bladder transitional cell carcinoma.
Mirjalili SM; Hashemipour S; Salehi S; Kazemifar AM; Madani PS
Malays J Pathol; 2016 Apr; 38(1):65-70. PubMed ID: 27126668
[TBL] [Abstract] [Full Text] [Related]
9. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.
Matthew EM; Zhou L; Yang Z; Dicker DT; Holder SL; Lim B; Harouaka R; Zheng SY; Drabick JJ; Lamparella NE; Truica CI; El-Deiry WS
Oncotarget; 2016 Jan; 7(4):3662-76. PubMed ID: 26695546
[TBL] [Abstract] [Full Text] [Related]
10. thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT.
Eccles A; Challapalli A; Khan S; Barwick T; Mangar S
Clin Nucl Med; 2013 Sep; 38(9):755-7. PubMed ID: 23856826
[TBL] [Abstract] [Full Text] [Related]
11. What are the keys to successful thyroid FNA interpretation?
Sebo TJ
Clin Endocrinol (Oxf); 2012 Jul; 77(1):13-7. PubMed ID: 22469035
[TBL] [Abstract] [Full Text] [Related]
12. Metastatic prostate cancer on the thyroid cartilage: unusual symptoms of prostatic adenocarcinoma. Case report.
Escudero RM; Amo FH; Martínez MC; Jiménez JT; Alonso AH; Piniés GO; Fernández CH
Arch Esp Urol; 2011 Mar; 64(2):132-5. PubMed ID: 21422500
[TBL] [Abstract] [Full Text] [Related]
13. diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy.
Iizuka Y; Iizuka H; Tsutsumi S; Nakagawa Y; Nakajima T; Sorimachi Y; Ara T; Nishinome M; Seki T; Takagishi K
Eur Spine J; 2009 Oct; 18(10):1431-5. PubMed ID: 19533181
[TBL] [Abstract] [Full Text] [Related]
14. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract] [Full Text] [Related]
15. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract] [Full Text] [Related]
16. The role of P501S and psa in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract] [Full Text] [Related]
17. Osteoporosis management in prostate cancer patients treated with androgen deprivation therapy.
Yee EF; White RE; Murata GH; Handanos C; Hoffman RM
J Gen Intern Med; 2007 Sep; 22(9):1305-10. PubMed ID: 17634780
[TBL] [Abstract] [Full Text] [Related]
18. [Prostate cancer metastasized to thyroid cartilage: a case report].
Nohara T; Kawashima A; Takahashi T; Kitamura M; Akai H; Oka T; Mano M
Nihon Hinyokika Gakkai Zasshi; 2005 Nov; 96(7):697-700. PubMed ID: 16363656
[TBL] [Abstract] [Full Text] [Related]
19. Expression of prostate-specific antigen (psa) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
Olsson AY; Bjartell A; Lilja H; Lundwall A
Int J Cancer; 2005 Jan; 113(2):290-7. PubMed ID: 15389512
[TBL] [Abstract] [Full Text] [Related]
20. [A case of primary transitional cell carcinoma of the prostate].
Morikawa H; Cho M; Takada S; Fujimoto K; Uemura H; Ozono S; Hirao Y; Natsume O
Hinyokika Kiyo; 2003 Jun; 49(6):357-60. PubMed ID: 12894737
[TBL] [Abstract] [Full Text] [Related]
[Next]
